These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1182 related articles for article (PubMed ID: 11967553)

  • 1. Listening to silence and understanding nonsense: exonic mutations that affect splicing.
    Cartegni L; Chew SL; Krainer AR
    Nat Rev Genet; 2002 Apr; 3(4):285-98. PubMed ID: 11967553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.
    Liu HX; Cartegni L; Zhang MQ; Krainer AR
    Nat Genet; 2001 Jan; 27(1):55-8. PubMed ID: 11137998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The power of point mutations.
    Maquat LE
    Nat Genet; 2001 Jan; 27(1):5-6. PubMed ID: 11137984
    [No Abstract]   [Full Text] [Related]  

  • 4. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
    Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
    Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
    Ridout CK; Keighley P; Krywawych S; Brown RM; Brown GK
    Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
    Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
    Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
    Gorlov IP; Gorlova OY; Frazier ML; Amos CI
    Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a splicing enhancer in MLH1 using COMPARE, a new assay for determination of relative RNA splicing efficiencies.
    Xu DQ; Mattox W
    Hum Mol Genet; 2006 Jan; 15(2):329-36. PubMed ID: 16357104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
    Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
    Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.
    Kouidou S; Malousi A; Maglaveras N
    Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6.
    Raponi M; Kralovicova J; Copson E; Divina P; Eccles D; Johnson P; Baralle D; Vorechovsky I
    Hum Mutat; 2011 Apr; 32(4):436-44. PubMed ID: 21309043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
    Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
    Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of pre-mRNA splicing on phenotypic modification in Stickler's syndrome and other type II collagenopathies.
    Richards AJ; Snead MP
    Eye (Lond); 2008 Oct; 22(10):1243-50. PubMed ID: 18309338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASA E382K disrupts a potential exonic splicing enhancer and causes exon skipping, but missense mutations in ASA are not associated with ESEs.
    Shotelersuk V; Desudchit T; Tongkobpetch S
    Int J Mol Med; 2004 Oct; 14(4):683-9. PubMed ID: 15375602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strength of the purifying selection against different categories of the point mutations in the coding regions of the human genome.
    Gorlov IP; Kimmel M; Amos CI
    Hum Mol Genet; 2006 Apr; 15(7):1143-50. PubMed ID: 16500998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional splicing assay of DSPP mutations in hereditary dentin defects.
    Lee KE; Lee SK; Jung SE; Lee Zh; Kim JW
    Oral Dis; 2011 Oct; 17(7):690-5. PubMed ID: 21736673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity.
    Nornes S; Newman M; Verdile G; Wells S; Stoick-Cooper CL; Tucker B; Frederich-Sleptsova I; Martins R; Lardelli M
    Hum Mol Genet; 2008 Feb; 17(3):402-12. PubMed ID: 17981814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of missense/nonsense mutations in exonic splicing enhancer sequences from cancer-related human genes.
    Jin P; Cai R; Zhou X; Li-Ling J; Ma F
    Mutat Res; 2012 Dec; 740(1-2):6-12. PubMed ID: 23123687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex expression pattern of RPGR reveals a role for purine-rich exonic splicing enhancers.
    Hong DH; Li T
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3373-82. PubMed ID: 12407146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.